HERON THERAPEUTICS, INC. /DE/ Earnings Per Share, Basic and Diluted
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Earnings Per Share, Basic and Diluted of -$0.63 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-09
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.63.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.54.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.51.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.62.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for fiscal 2021 was -$2.24.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for fiscal 2020 was -$2.50.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for fiscal 2019 was -$2.50.
- HERON THERAPEUTICS, INC. /DE/ earnings per share, basic and diluted for fiscal 2018 was -$2.44.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.63 10-Q · filed 2022-05-09 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.68 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.30 derived: net income ÷ weighted average shares · filed 2026-04-30 | ||||
| 2021-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$1.67 derived: net income ÷ weighted average shares · filed 2026-04-30 | -$2.24 10-K · filed 2022-02-28 | ||||
| 2021-09-30 | -$0.51 10-Q · filed 2021-11-03 | -$1.13 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.71 10-Q · filed 2021-11-03 | -$2.39 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2021-06-30 | -$0.62 10-Q · filed 2021-08-09 | -$1.20 10-Q · filed 2021-08-09 | -$1.88 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.52 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2021-03-31 | -$0.58 10-Q · filed 2022-05-09 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.90 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$2.51 derived: net income ÷ weighted average shares · filed 2022-11-08 | ||||
| 2020-12-31 | -$0.68 10-K · filed 2021-02-24 | -$1.32 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.93 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.50 10-K · filed 2022-02-28 | ||||
| 2020-09-30 | -$0.64 10-Q · filed 2021-11-03 | -$1.25 derived: net income ÷ weighted average shares · filed 2021-11-03 | -$1.82 10-Q · filed 2021-11-03 | -$2.47 derived: net income ÷ weighted average shares · filed 2022-02-28 | ||||
| 2020-06-30 | -$0.61 10-Q · filed 2021-08-09 | -$1.18 10-Q · filed 2021-08-09 | -$1.83 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.26 derived: net income ÷ weighted average shares · filed 2022-02-28 | ||||
| 2020-03-31 | -$0.57 10-Q · filed 2021-05-10 | -$1.22 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.65 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.28 derived: net income ÷ weighted average shares · filed 2022-02-28 | ||||
| 2019-12-31 | -$0.65 10-K · filed 2021-02-24 | -$1.08 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.71 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.50 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | -$0.42 10-K · filed 2021-02-24 | -$1.05 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.85 10-Q · filed 2020-11-05 | -$2.49 derived: net income ÷ weighted average shares · filed 2021-02-24 | ||||
| 2019-06-30 | -$0.63 10-K · filed 2021-02-24 | -$1.43 10-Q · filed 2020-08-05 | -$2.07 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.56 derived: net income ÷ weighted average shares · filed 2021-02-24 | ||||
| 2019-03-31 | -$0.80 10-K · filed 2021-02-24 | -$1.44 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.93 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.48 derived: net income ÷ weighted average shares · filed 2021-02-24 | ||||
| 2018-12-31 | -$0.63 10-K · filed 2020-03-02 | -$1.13 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.67 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$2.44 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | -$0.49 10-K · filed 2020-03-02 | -$1.03 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$1.81 10-Q · filed 2019-11-12 | -$2.82 derived: net income ÷ weighted average shares · filed 2020-03-02 | ||||
| 2018-06-30 | -$0.54 10-K · filed 2020-03-02 | -$1.33 10-Q · filed 2019-08-05 | -$2.37 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$3.14 derived: net income ÷ weighted average shares · filed 2020-03-02 | ||||
| 2018-03-31 | -$0.81 10-K · filed 2020-03-02 | -$1.88 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.66 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$3.46 derived: net income ÷ weighted average shares · filed 2020-03-02 | ||||
| 2017-12-31 | -$1.09 10-K · filed 2019-02-22 | -$1.87 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$2.67 derived: net income ÷ weighted average shares · filed 2020-03-02 | -$3.65 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | -$0.77 10-K · filed 2019-02-22 | -$1.57 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$2.55 10-Q · filed 2018-11-07 | -$3.70 derived: net income ÷ weighted average shares · filed 2019-02-22 | ||||
| 2017-06-30 | -$0.80 10-K · filed 2019-02-22 | -$1.79 10-Q · filed 2018-08-08 | -$2.95 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$4.15 derived: net income ÷ weighted average shares · filed 2019-02-22 | ||||
| 2017-03-31 | -$1.00 10-K · filed 2019-02-22 | -$2.19 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$3.42 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$4.58 derived: net income ÷ weighted average shares · filed 2019-02-22 | ||||
| 2016-12-31 | -$1.22 10-K · filed 2018-02-27 | -$2.46 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$3.63 derived: net income ÷ weighted average shares · filed 2019-02-22 | -$4.56 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | -$1.24 10-K · filed 2018-02-27 | -$2.41 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$3.34 10-Q · filed 2017-11-06 | -$4.21 derived: net income ÷ weighted average shares · filed 2018-02-27 | ||||
| 2016-06-30 | -$1.17 10-K · filed 2018-02-27 | -$2.09 10-Q · filed 2017-08-09 | -$2.96 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$3.60 derived: net income ÷ weighted average shares · filed 2018-02-27 | ||||
| 2016-03-31 | -$0.92 10-K · filed 2018-02-27 | -$1.79 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.43 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$3.18 derived: net income ÷ weighted average shares · filed 2018-02-27 | ||||
| 2015-12-31 | -$0.87 10-K · filed 2017-02-23 | -$1.50 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.25 derived: net income ÷ weighted average shares · filed 2018-02-27 | -$2.95 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$0.63 10-K · filed 2017-02-23 | -$1.37 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.07 10-Q · filed 2016-11-08 | -$2.77 derived: net income ÷ weighted average shares · filed 2017-02-23 | ||||
| 2015-06-30 | -$0.74 10-K · filed 2017-02-23 | -$1.45 10-Q · filed 2016-08-08 | -$2.15 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.81 derived: net income ÷ weighted average shares · filed 2017-02-23 | ||||
| 2015-03-31 | -$0.70 10-K · filed 2017-02-23 | -$1.41 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.07 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.84 derived: net income ÷ weighted average shares · filed 2017-02-23 | ||||
| 2014-12-31 | -$0.71 10-K · filed 2016-02-19 | -$1.37 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.14 derived: net income ÷ weighted average shares · filed 2017-02-23 | -$2.87 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$0.66 10-K · filed 2016-02-19 | -$1.43 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$2.17 10-Q · filed 2015-11-06 | -$2.92 derived: net income ÷ weighted average shares · filed 2016-02-19 | ||||
| 2014-06-30 | -$0.78 10-K · filed 2016-02-19 | -$1.52 10-Q · filed 2015-08-07 | -$2.28 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$3.09 derived: net income ÷ weighted average shares · filed 2016-02-19 | ||||
| 2014-03-31 | -$0.74 10-K · filed 2016-02-19 | -$1.49 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$2.31 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$3.28 derived: net income ÷ weighted average shares · filed 2016-02-19 | ||||
| 2013-12-31 | -$0.75 10-K · filed 2015-03-13 | -$1.58 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$2.57 derived: net income ÷ weighted average shares · filed 2016-02-19 | -$3.42 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$0.84 10-K · filed 2015-03-13 | -$0.04 10-Q · filed 2013-11-12 | -$1.85 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$2.69 10-Q · filed 2014-11-06 | -$0.13 10-Q · filed 2013-11-12 | $0.34 derived: net income ÷ weighted average shares · filed 2015-03-13 | ||
| 2013-06-30 | -$1.01 10-K · filed 2015-03-13 | -$0.05 10-Q · filed 2013-08-08 | -$1.86 10-Q · filed 2014-08-04 | -$0.09 10-Q · filed 2013-08-08 | $0.18 derived: net income ÷ weighted average shares · filed 2015-03-13 | $0.53 derived: net income ÷ weighted average shares · filed 2015-03-13 | ||
| 2013-03-31 | -$0.85 10-Q · filed 2014-05-12 | -$0.04 10-Q · filed 2013-05-10 | $0.07 derived: net income ÷ weighted average shares · filed 2015-03-13 | $0.24 derived: net income ÷ weighted average shares · filed 2015-03-13 | $0.37 derived: net income ÷ weighted average shares · filed 2015-03-13 | |||
| 2012-12-31 | -$0.51 10-K · filed 2014-03-07 | -$0.03 10-K · filed 2013-03-01 | $0.08 derived: net income ÷ weighted average shares · filed 2015-03-13 | $0.16 derived: net income ÷ weighted average shares · filed 2015-03-13 | -$1.91 10-K · filed 2015-03-13 | -$0.10 10-K · filed 2013-03-01 | ||
| 2012-09-30 | -$0.45 10-K · filed 2014-03-07 | -$0.02 10-Q · filed 2012-11-05 | -$0.08 derived: net income ÷ weighted average shares · filed 2014-03-07 | -$0.07 10-Q · filed 2013-11-12 | ||||
| 2012-06-30 | -$0.46 10-K · filed 2014-03-07 | -$0.02 10-Q · filed 2012-08-09 | -$0.05 10-Q · filed 2013-08-08 | |||||
| 2012-03-31 | -$0.85 10-K · filed 2015-03-13 | -$0.02 10-Q · filed 2012-05-10 | ||||||
| 2011-12-31 | -$0.02 10-K · filed 2013-03-01 | -$1.96 10-K · filed 2014-03-07 | -$0.10 10-K · filed 2012-03-26 | |||||
| 2011-09-30 | -$0.02 10-K · filed 2013-03-01 | -$0.08 10-Q · filed 2012-11-05 | ||||||
| 2011-06-30 | -$0.05 10-K · filed 2013-03-01 | -$0.08 10-Q · filed 2012-08-09 | ||||||
| 2011-03-31 | -$0.04 10-K · filed 2013-03-01 | |||||||
| 2010-12-31 | -$0.19 10-K · filed 2013-03-01 | |||||||
| 2010-09-30 | -$0.04 10-Q · filed 2011-11-07 | -$0.15 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | -$0.09 10-Q · filed 2011-08-08 | -$0.10 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | -$0.31 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |